BNCT for locally recurrent head and neck cancer: preliminary clinical experience from a phase I/II trial at Tsing Hua Open-Pool Reactor.

Category Primary study
JournalApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Year 2011
To introduce our preliminary experience of treating locally and regionally recurrent Head and Neck cancer patients at Tsing Hua Open-Pool Reactor in Taiwan, four patients (M/F=3/1, median age 68 Y/O) were enrolled. BNCT with BPA (400 mg/kg) injected in 2 phases and prescription dose of 12-35 Gy (Eq.)/fraction for 2 fractions at 30 day interval can be given with sustained blood boron concentration and tolerable early toxicities for recurrent H & N cancer.
Epistemonikos ID: 20bf7ec693ddb0aace215be4f3557287fb07b673
First added on: Oct 03, 2023